![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Characterization of Serologic Responses
Following ALT Flares in >3000 CHB Patients
Pooled from 5 Clinical Trials
|
|
|
EASL 2020 Aug 27-29 virtual
Maurizia Brunetto1, Wan-Long Chuang2, Patrick Marcellin3, Thomas Berg4, Hongyuan Wang5, Vithika Suri5, Lanjia Lin5, John F. Flaherty5, Anuj Gaggar5, Edward Gane6, Maria Buti7, Kosh Agarwal8
1University Hospital of Pisa, Pisa, Italy; 2Kaohsiung Medical University Hospital; 3AP-HP Hôpital Beaujon, Clichy, France; 4University Hospital Leipzig, Germany; 5Gilead Sciences Inc., Foster City, CA, USA; 6Auckland Clinical Studies, Auckland, New Zealand; 7Hospital General Universitario Valle Hebron and CIBERehd, Barcelona, Spain; 8Institute of Liver Studies, King's College Hospital, London, UK
![0918201](../images/091820/091820-7/0918201.gif)
![0918202](../images/091820/091820-7/0918202.gif)
![0918203](../images/091820/091820-7/0918203.gif)
![0918204](../images/091820/091820-7/0918204.gif)
![0918205](../images/091820/091820-7/0918205.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|